-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopausal-symptoms-protocol-final.pdf
October 15, 2024 - Criteria Inclusions Exclusions
Subgroups of interest (preplanned only):
Route of delivery: oral … We will also use
it to prioritize citations for screening. … We will also use DistillerSR’s AI feature to prioritize full-text articles for screening. … Trends in oral and vaginally administered estrogen
use among US women 50 years of age or older with … or
ospemifen* or prasteron* or progesteron* or
progestin* or testosteron* or triestrogen*) adj1
(oral
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopausal-symptoms-protocol.pdf
October 15, 2024 - facilities),b
“bioidentical hormones”
Subgroups of interest (preplanned only):
Route of delivery: oral … We will also use
it to prioritize citations for screening. … We will also use DistillerSR’s AI feature to prioritize full-text articles for screening. … Trends in oral and vaginally administered estrogen
use among US women 50 years of age or older with … or
ospemifen* or prasteron* or progesteron* or
progestin* or testosteron* or triestrogen*) adj1
(oral
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
May 01, 2022 - Department of Health and Human Services. … from this report, such as clinical practice guidelines, other quality enhancement tools, or reimbursement … AHRQ Methods for Effective Health Care. … Health Technol Assess. 2015;19(12):1-187.
PMID: 25676540. … : Multifaceted health
hazards and health benefits of Cannabis
sativa and its phytochemicals.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/registries-forums_research_0.pdf
May 01, 2014 - of research centers that
support the rapid development of new scientific information and analytic tools … pre-service education,16 occupational therapy,17 equine science and
management,18 orthopedic surgery,19 and oral … Finally, a Web site can offer
concrete tools, which are discussed further in the subsequent sections … Use of
Web 2.0 tools and technologies for science
communication in biomedical sciences: A
special … Use of
Web 2.0 tools and technologies for science
communication in biomedical sciences: A
special
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1406.pdf
June 01, 2014 - Effectiveness
Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments, screening … A third topic that was in the December 2013 report, the oral tablet ivacaftor
(Kalydeco™, Vertex Pharmaceuticals … Zithromax (azithromycin tablets) and (azithromycin
for oral suspension) prescribing information. … Zithromax (azithromycin tablets) and (azithromycin
for oral suspension) prescribing information.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol.pdf
November 03, 2014 - treatment (KQ1, 4, 5b)
• Anti-inflammatories (NSAIDS, corticosteroids [intra-
articular and/or oral … ])
• Microtubule inhibitors (colchicine)
• Combination therapy (colchicine and NSAIDS/ oral
corticosteroids … The DistillerSR software package will be used to manage the search outputs,
screening, and data abstraction … Rockville, MD: Agency for Health Care Research and
Quality, Effective Health Care Program,; July 17, … Cholesterol screening guidelines. Consensus, evidence,
and common sense.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_research-protocol.pdf
June 05, 2014 - ., calorie and fat reduced while
controlling carbohydrate intake) and then, if needed, one or more oral … While these tools show great promise for
helping health systems meet the growing demand for diabetes … outcomes
• Quality of life (e.g., validated tools for health-related quality of life, life satisfaction … While these tools show great promise for helping health
systems meet the growing demand for diabetes … They do not include interventions limited to screening or therapeutic
counseling for mental health diagnoses
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_disposition-comments.pdf
March 01, 2012 - Develop tools to ensure data
consistency and oversight of research.
3) Establish objective diagnostic … Effect of BAY
59-7939–a novel, oral, direct factor Xa inhibitor–on clot-
bound factor Xa activity in … Value Health 2:288–294. … extended period
of prophylaxis as used in the present clinical
environment since venographic or other screening … prophylaxis
are relatively inexpensive compared to other drugs or
healthcare costs (including ultrasound screening
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-careassociated-infections_disposition-comments.pdf
November 30, 2012 - The Jain study is
reviewed in our forthcoming CER of MRSA
screening.
13 Peer Reviewer
#2
General … George, Utah (Intermountain Health
Care). … Care Section -- important to note frequency of oral care as
this varies by study (Q 12 hrs, Q6 hrs, … Q4 hrs
etc); also need to note if oral care performed with an antiseptic
such as chlorhexidine. … MRSA and C Diff are addressed in other AHRQ
CERs.
1) Comparative Effectiveness of Screening for
-
effectivehealthcare.ahrq.gov/sites/default/files/11_pepticulcer_potential_high_impact_june_2012.pdf
January 01, 2012 - Effectiveness
Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures, treatments, screening … Treatment
for severe SBS may involve oral rehydration solutions, intravenous nutrition delivery, and … aminosalicylates, oral prednisone, topical agents (e.g., mesalamine, corticosteroids), and/or anti … Per oral
endoscopic myotomy - a stepwise approach
[abstract Sp706].
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy-2011_research.pdf
January 01, 2011 - None of the tools discriminated
poor reporting quality from overall quality. … None of the tools gave separate conclusions about
external and internal validity. … relationships: an
analysis of methodologic problems as
illustrated by the conflicting data for the role
of oral … Association between fruit and vegetable
consumption and oral cancer: a meta-
analysis of observational … Improving the completeness and
transparency of reports of randomized trials
in oral health: the CONSORT
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
April 17, 2012 - Effectiveness Research,
AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures, treatments, screening … Naltrexone/bupropion combination
drug is an oral, sustained-release drug intended to fight the body's … pressure for lorcaserin patients compared
to placebo overall.
12
Lorcaserin is a self-administered oral … Phentermine + Topiramate (oral, obesity/type 2
diabetes). [28 p].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause-protocol-130612.pdf
June 12, 2013 - Treatments of interest include:
• Hormone therapies
o Oral estrogen only or combined with progestin … therapy including estrogen therapy and estrogen-progestin (or estrogen-androgen)
therapy administered by oral … A decision whether to adopt initial title screening instead of title/abstract screening
will be based … screening. … Department of Health and Human Services.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/acute-pain-protocol-amended.pdf
June 10, 2018 - We will search the ECRI Guidelines Trust resource23
provider point of care tools (e.g., DynaMed, UpToDate … Department of Health & Human Services. … Acute pain assessment tools: let us move beyond simple pain ratings. … Department of Health and Human Services. … outpatient surgical facilities
o Primary care clinics
o Specialty care clinics
o Dental clinics
o Oral
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy_research-protocol.pdf
September 14, 2016 - including immunostimulatory adjuvants,
recombinant allergens, T-cell tolerizing constructs, and improved oral … based on its perceived improved safety margin (reduced risk of anaphylaxis), simple
and convenient oral … Asthma cases attributable to atopy: results from
the Third National Health and Nutrition Examination … Grading the strength of a body of evidence
when assessing health care interventions: an EPC update. … GRADE's software for Summary of Findings tables, Health Technology
Assessment and Guidelines. 2015.
-
effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual_130826.pdf
August 01, 2013 - Questions considered about screening and diagnostic interventions ................................ 8 … Changes in formulation (e.g., from
injection administered by a clinician to an oral pill) or dosing … Questions considered about screening and diagnostic interventions
1. … Is this a surgical procedure that requires use of procedure-specific tools or devices in development? … Are the tools subject to approval under FDA’s premarket notification (510k) or Premarket Approval
(
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/menopause_research-protocol.pdf
March 25, 2012 - Treatments of interest include:
• Hormone therapies
o Oral estrogen only or combined with progestin … therapy including estrogen therapy and estrogen-progestin (or estrogen-androgen)
therapy administered by oral … A decision whether to adopt initial title screening instead of title/abstract screening
will be based … screening. … Department of Health and Human Services.
-
effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
June 01, 2013 - Effectiveness
Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures, treatments, screening … Placebo-
controlled phase 3 study of oral BG-12 for
relapsing multiple sclerosis. … Tecfidera (dimethyl fumarate) delayed-release
capsules, for oral use prescribing information. … Placebo-
controlled phase 3 study of oral BG-12 or
glatiramer in multiple sclerosis.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetic-neuropathy_research-protocol.pdf
May 09, 2016 - Quality (AHRQ) reviews, including recent and ongoing Evidence-Based Practice Center (EPC)
review on oral … We will use DistillerSR (Evidence Partners, 2010) to manage the screening process. … Abstract screening: Two reviewers will independently review abstracts, which will be
excluded if both … Full-text screening: Citations promoted on the basis of abstract screen will undergo
another independent … As for all forms (screening, assessment and
abstraction), we will pilot test forms to identify any changes
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
January 31, 2013 - patency rates and longevity seen with angioplasty and stenting,
atherectomy devices have gained favor as tools … Articles included by either reviewer will undergo full-text screening. … At the full-text
screening stage, two independent reviewers must agree on a final inclusion/exclusion … Department of Health and Human Services. … Department of Health and Human Services.